)

Prime Medicine (PRME) investor relations material
Prime Medicine Morgan Stanley 23rd Annual Global Healthcare Conference summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Strategic priorities and capital allocation
Focused on programs with high probability of early de-risking, unmet medical need, and strong commercial potential, especially two liver programs: Wilson’s disease and Alpha-1 antitrypsin deficiency.
Cystic fibrosis program is advancing with funding from the Cystic Fibrosis Foundation; delivery remains a challenge but progress is ongoing.
Ex vivo CAR-T cell therapy collaboration with Bristol Myers Squibb is progressing, with potential for future proprietary and partnered programs in neurological and other diseases.
Long-term vision includes leveraging Prime Editing’s unique capabilities for neurological and other high-value indications.
Capital allocation is focused on core programs, with future expansion possible as opportunities arise.
Differentiation and technology platform
Prime Editing offers safer, more precise gene editing compared to CRISPR-Cas9, avoiding double-stranded breaks and off-target effects.
The technology enables writing multiple base pairs, expanding the range of treatable diseases beyond what base editing or CRISPR can achieve.
Regulatory outlook is favorable due to the platform’s ability to restore wild-type protein without bystander edits, potentially easing approval pathways.
Clinical and preclinical program updates
First clinical program in chronic granulomatous disease showed high editing efficiency and strong biomarker response, but limited commercial opportunity led to no further investment.
Plans to discuss potential regulatory paths with the FDA for this program within the next six months.
High editing efficiency demonstrated in multiple tissue types; delivery is the main focus for in vivo applications, with lipid nanoparticles used for liver targeting.
Next Prime Medicine earnings date

Next Prime Medicine earnings date

The essential earnings season companion
The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
I can't remember the last time an app had such a positive impact on my investment process.
)
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
)
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
)
)
)
)
Frequently asked questions
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Explore our global coverage